NCT05582161View on ClinicalTrials.gov

Efficacy Biomarkers of DAOIB for Dementia

PHASE2RecruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Dementia
Interventions
DRUG

DAOIB

The DAOIB dose will be adjusted every 8 weeks according to clinical evaluation.

Trial Locations (2)

886

RECRUITING

Chang Gung Memorial Hospital, Kaohsiung City

Unknown

RECRUITING

China Medical University Hospital, Taichung

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER